Journal of Postgraduate Medicine
 Open access journal indexed with Index Medicus & ISI's SCI  
Users online: 1053  
Home | Subscribe | Feedback | Login 
About Latest Articles Back-Issues Article Submission Resources Sections Etcetera Contact
 
  NAVIGATE Here 
  Search
 
 :: Next article
 :: Previous article 
 :: Table of Contents
  
 RESOURCE Links
 ::  Similar in PUBMED
 ::  Search Pubmed for
 ::  Search in Google Scholar for
 ::  [PDF Not available] *
 ::  Citation Manager
 ::  Access Statistics
 ::  Reader Comments
 ::  Email Alert *
 ::  Add to My List *
* Registration required (free) 

  IN THIS Article
 ::  Abstract
 ::  Introduction
 ::  Material and Methods
 ::  Results
 ::  Discussion
 ::  Acknowledgement
 ::  References
 ::  Article Figures
 ::  Article Tables

 Article Access Statistics
    Viewed2187    
    Printed97    
    Emailed0    
    PDF Downloaded0    
    Comments [Add]    

Recommend this journal


 


 
ARTICLE
Year : 1976  |  Volume : 22  |  Issue : 2  |  Page : 66-75

Structure activity relationship of disubstituted piperazine compounds


Department of Pharmacology and Pharmacology Research Unit CSIR. Seth G. S. Medical College, Parel, Bombay 400 012, India

Correspondence Address:
N K Dadkar
Hoechst Research Centre, Mulund, Bombay 400 080.
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


PMID: 25964

Rights and PermissionsRights and Permissions


 :: Abstract 

The various compounds belonging to the 1-4 disubstituted piperazine series exhibited the adrenolytic, hypotensive and CNS depressant activities. Appropriate substitution could also lead, to a dissociation of these pharmacological effects. It was observed that adrenolytic and CATS depressant but not the hypotensive pro­perty of these compounds was greatly susceptible to structural changes in their molecular configuration and a relationship was evident between adrenolytic and hypotensive activity as well as between CNS depressant and hypotensive activity with different structural variations.



How to cite this article:
Dadkar N K, Dadkar VN, Deliwala C V, Sheth U K. Structure activity relationship of disubstituted piperazine compounds. J Postgrad Med 1976;22:66-75

How to cite this URL:
Dadkar N K, Dadkar VN, Deliwala C V, Sheth U K. Structure activity relationship of disubstituted piperazine compounds. J Postgrad Med [serial online] 1976 [cited 2019 Sep 22];22:66-75. Available from: http://www.jpgmonline.com/text.asp?1976/22/2/66/42835



 :: Introduction Top


Since Bovet and Bovet Nitti [3] reported the reversal of the epinephrine pressor response by phenylpiperazine and 1-methyl 4-phenylpiperazine compounds, the blockade of the adrenergie receptor has been recognized as being a component of action of certain piperazine compounds. It has been observed by many workers that phenylpiperazine series contain com­pounds with very potent adrenolytic and hypotensive actions [8],[13] and even include compounds which show significant seda­tive tranquillizing activity. [6],[7],[8],[9]

A series of disubstituted piperazine derivatives General formula: see [Figure 1] synthesized at the Haffkine Institute, Bombay were found to possess the ability to induce central nervous system (CNS) depression [11],[12] . Further pharmacological studies of these compounds revealed, in some of them, the ability to cause a fall in systemic blood pressure and blockade of alpha adrenergic receptors.

The purpose of this study was an attempt to determine the pharmacological effects produced by modification of the chemical structure in a series of piper­azine derivatives. The relation of the changes in the chemical configuration of this series of compounds to their primary pharmacological actions viz. CNS de­pression, alpha-adrenerrgic blockade and hypotension were determined.


 :: Material and Methods Top


Toxicity studies: The test compounds were administered intraperitoneally (i.p) to albino mice of either sex (Haffkine strain), weighing 20-25 gm in doses of 10, 50, 100, 200, 400, 800 mg/kg; 1% aqueous gum acacia was used as a vehicle. Six animals were used in each group, and the group treated with the vehicle alone served as control. Approximate LD 50 was determined by recording the percent­age mortality of each dose level.

Pharmacological studies

Locomotor activity: Spontaneous motor activity studies were carried out in male albino mice (20-25 gm), by photocell method of Dews. [4] The activity was recorded using actophotometer before and after the treatment with the test compounds (1/10th of LD 50 , i.p.); at the peak of drug action, percentage inhibition was calculated. Three groups (6 mice per group) were studied at each dose level, the animals treated with 1% aqueous gum acacia served as control.

Blood pressure and adrenolytic activity: Hypotensive and adrenergic blocking activity were determined in Mongrel dogs of either sex weighing from 10-16 kg. Animals were anaesthetised with pentobarbital sodium (35.0 mg/kg i.v.), anaesthesia was repeated in small doses when and if necessary. The trachea was cannulated and arterial blood pressure was recorded by means of a mercury manometer. All the animals were main­tained on positive artificial ventilation. Drugs were injected through the cannul­ated femoral vein and the animals were observed for a period of 4-6 hours after the administration of test compounds in doses of 1.0, 2.5, 5.0 and 10 mg/kg i. v. in the form of a suspen­sion using carboxy methyl cellulose (CMC) as a suspending agent. The effect of compounds was assessed on (a) systemic blood pressure, (b) pressor response of epinephrine (2.5 µg/kg), (c) pressure response of nor-epinephrine (2.5 µg/kg) at various time intervals following the administration of test compounds.

Only an actual reversal of the blood pressure response to epinephrine was selected as the criterion of adrenergic blocking activity because mere reduction of the pressor response could result from a number of nonspecific factors as sug­gested by Nickerson. [10] Minimal effective dose of the compound producing a rever­sal of the epinephrine induced pressor response was determined.

In comparative studies of the effect of compounds on blood pressure, the initial blood pressure of the animal was taken as 100 and the per cent change over this initial value was calculated. The fall in blood pressure on administration of com­pounds lasting for a period of at least 10-15 minutes was considered for compa­rative studies. When the fall in blood pressure was to an extent of 40% or more, the fall was prolonged, the initial read­ing could not be attained within a period of 2 to 3 hours.


 :: Results Top


In order to correlate the effect of changes of structure on biological acti­vity, substitution in different parts (i.e. A, B and C) of the prototype are con­sidered separately [Table 1].

When phenyl group was attached di­rectly at N 4 (I) it showed both adreno­lytic and hypotensive activity. The cor­responding benzyl (X) and methyl (VIII) compounds had very weak adre­nolytic and no hypotensive and no CNS depressant activity. Ortho substituted phenyl compounds showed both adreno­lytic and hypotensive activity and vary­ing degree of CNS depressant activity. This CNS depressant activity was most marked in ortho methoxy phenyl (V) and ortho methyl LIII) substitution. With para substitution the compounds possess­ed very weak adrenolytic and poor hypo­tensive activity (VI, VII). In the corre­sponding 2-pyridyl (XI) and 2-pyrimidyl (XII) compounds a dissociation of adre­nolytic and hypotensive activity was evi­dent, the former being more marked than the latter. Both groups possessed weak CNS depressant activity.

An increase in chain length at bridge-­X-from one carbon atom to three carbon atoms showed increase in adrenolytic, hypotensive and CNS depressant activi­ties. The direct attachment of -CO- at N 1 decreased adrenolytic, hypotensive and CNS depressant activity (XVI-XX). When -CO- was replaced by CH 2 -there was not much change seen in these acti­vities (XXI, XXII). When CO-CH 2 -CH 2 was changed to CH=CH-CO-CH 2 -CH 2 (XXIII-XXVI) an increase in hypoten­sive and CNS depressant activity occur­red, but when the same was changed to CO-O- (CH 2 ) 4 (XXIX-XXXII), there was decrease in CNS depressant activity while adrenolytic and hypotensive acti­vity was unchanged. Increase in adreno­lytic and a decrease in CNS depressant activity was seen when CH=CH-CO-­CH 2 -CH 2 , was reduced to CH=CH-­CHOH-CH 2 -CH 2 (XXVII, XXVIII).

When trimethoxy phenyl moiety was changed to mono methoxy phenyl or simple phenyl, there was increase in adrenolytic activity, decrease in CNS depressant activity, but there was no change in hypotensive activity [Table 2].


 :: Discussion Top


The various compounds belonging to the 1-4-disubstituted piperazine series ex­hibited the adrenolytic, hypotensive and CNS depressant activities. Appropriate substitution could also lead to a disso­ciation of these pharmacological effects. On this basis, the following conclusions may be drawn.

The direct attachment of phenyl ring to N 4 seemed necessary as the correspond­ing benzyl and methyl compounds had a weak adrenolytic activity and no hypo­tensive and CNS depressant activity.

Ortho substitution at the phenyl ring was associated with both the adrenolytic as well as hypotensive activity but varia­tions in CNS depressant activity. The activity was found to be most marked in o-methoxy or o-tolyl substitution but weak for o-chloro and o-fiuoro substitu­tion.

A shift in the substitution from the ortho to the para position in the phenyl ring (at N 4 ) reduced both the adreno­lytic as well as hypotensive activity. This finding has been described by Ghouri. [5] It could possibly be explained by the differences in the geometry of the mole­cule., In the para and unsubstituted N­-phenyl piperazinyl compounds, the phenyl group might be expected to lie in the plane almost parallel to the pipera­zine ring thus permitting an overlap of the nitrogen lone pair and the π electrons of the phenyl group. However, when there was ortho substituent on N-phenyl part, it would impinge upon an equato­rial hydrogen atom in the piperazine ring and would twist the phenyl ring into an almost perpendicular plane as suggested by Anand. [1]

Structural alterations at bridge -X-. which joins the trimethoxy phenyl moiety to the piperazine nucleus led to the fol­lowing observations.

The direct attachment of -CO- at N 1 abolished the adrenolytic, hypotensive and CNS depressant properties. This was suggestive that basicity of N 1 was necessary for all these activities.

The adrenolytic, hypotensive and CNS depressant activity was found to increase progressively with an increase in the number of carbon atoms (i.e. from one carbon atom to three carbon atoms) in bridge X. It was observed that the mini­mum chain length of three carbon atoms was essential for fairly goad adrenolytic, hypotensive and CNS depressant activity.

When the trimethoxy phenyl moiety at `C' was changed to either mono methoxy or simple phenyl moiety, CNS activity was markedly reduced but the adreno­lytic and hypotensive activity was not markedly affected. Thus the trimethoxy moiety seemed to be essential for CNS depressant activity as described by Bois­sier. [2] This could be due to an electron donation by this group which might be useful in non-effective charge transfer association with no acceptor species on the receptor site.

As a result of this study, it was evident that the adrenolytic and CNS depressant but not the hypotensive property of these compounds was greatly susceptible to structural changes in their molecular configuration. Similar findings have been described by Morphis [8] in a series of 1-4 disubstituted piperazine com­pounds.

No firm conclusion could be drawn regarding the degree of effectiveness of these compounds as adrenolytic, hypo­tensive or CNS depressant agents, as these activities showed varying degrees of susceptibility to the same structural alteration. But a relationship was evident between the adrenolytic and hypotensive activity as well as between the CNS de­pressant and hypotensive activity with different structural variations. However, a particular mention must be made here in relation to N 4 -2 pyridyl compounds which showed marked adrenolytic acti­vity with minimal hypotensive and CNS depressant activity.


 :: Acknowledgement Top


The authors express their appreciation to Dr. Nitya Anand, Director Central Drug Research Institute,, Lucknow, India, for his valuable sug­gestion.

 
 :: References Top

1.Anand, N.: Organic molecules-relation of structure and function. Science and Culture 34: 6-16, 1968.  Back to cited text no. 1    
2.Boissier, J. R., Ratouis, R. and Dumont.C.: Synthesis and pharmacological study of new piperazine derivatives I, Benzyl piperazines. J. Med. Chem. 6: 541-544. 1533.  Back to cited text no. 2    
3.Bovet, D. and Bovet Nitti: Medicaments du systeme Nerveux Vegetalif. 247-271, Karger, Basel, 1948.  Back to cited text no. 3    
4.Dews, P. B.: Measurement of influence of drugs on voluntary activity in mice Brit. J. Pharmacol. 8: 46-48, .1953.  Back to cited text no. 4    
5.Ghouri, M. S. K. and Haley, T. J.: Alpha adrenergic blocking properties of six phenethylamine derivatives in vitro. J. Pharmaceutical Sci. 58: 760-761, 1969.  Back to cited text no. 5    
6.Hayao, S. and Schut, R. N.: New seda­tive and hypotensive phenylpiperazine amides. J. Org. Chem. 26: 3414-3419, 1961.  Back to cited text no. 6    
7.Hayao, S., Schut, R. N. and Strycker, W. G.: New sedative and hypotensive phenylpiperazine esters and carbamate. J. Med. Chem. 6: 133-135, 1963.  Back to cited text no. 7    
8.Morphis, B. B., Roth, L. W. and Rich­ards, R. K.: Pharmacologic studies of a new antihypertensive compound N-(O­-methoxyphenyl)-N'-(3 methoxy-propyl).­piperazine phosphate (HT-1479). Proc. Soc. Experimental Biol. Med. 101: 174­177, 1959.  Back to cited text no. 8    
9.Morren, H. G.: Bienfeen and Reyntjens, A. M.: Psycho-pharmacological agents. Academic Press, N. Y. 1: 251-285, 1964.  Back to cited text no. 9    
10.Nickerson, M. and Gump, W. S.: Chemi­cal basis for adrenergic blocking activity in compounds related to dibenamine. J.Pharmacol. exp. Ther. 97: 25-47, 1949.  Back to cited text no. 10    
11.Petigara, R. B., Deliwala, C. V., Man­drekar, S. S., Dadkar, N. K. and Sheth, U. K.: Synthesis and central nervous system depressant activity of new piper­azine and related to derivatives II. J. Med. Chem. 12: 865-870, 1969.  Back to cited text no. 11    
12.Petigara, R. B., Deliwala, C. V., Man­drekar, S. S. and Sheth, U. K.: Synthe­sis and central nervous system depressant activity of new piperazine derivatives I. J. Med. Chem. 11: 332-336, 1968.  Back to cited text no. 12    
13.Roth, L. W.: Blocking effects of series of substituted piperazine. J. Pharmacol. exp. Ther. 110: 174-177, 1954.  Back to cited text no. 13    


    Figures

  [Figure 1]
 
 
    Tables

  [Table 1], [Table 2]



 

Top
Print this article  Email this article
Previous article Next article
Online since 12th February '04
© 2004 - Journal of Postgraduate Medicine
Official Publication of the Staff Society of the Seth GS Medical College and KEM Hospital, Mumbai, India
Published by Wolters Kluwer - Medknow